Technology: CAR-T, Cell_Therapies
Industry: Gene therapy, Public
Headquarters: Somerville, Massachusetts, United States
Founded Date: 1993-01-01
Employees Number: 501-1000
Funding Status: IPO
Investor Type: N/A
Investment Stage: N/A
Number Of Exits: 1
Investors Number: 13
Total Funding: 593350000
Estimated Revenue: $10M to $50M
Last Funding Date: 2023-01-18
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership